FFVAX | FPTKX | FFVAX / FPTKX | |
Total Expense Ratio | 0.77 | 0.26 | 296% |
Annual Report Gross Expense Ratio | 0.77 | 0.26 | 296% |
Fund Existence | 22 years | 8 years | - |
Gain YTD | 4.324 | 5.213 | 83% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 436M | 4.38B | 10% |
Annual Yield % from dividends | 2.41 | 3.00 | 81% |
Returns for 1 year | 4.79 | 6.23 | 77% |
Returns for 3 years | 18.83 | 22.15 | 85% |
Returns for 5 years | 3.62 | 7.40 | 49% |
Returns for 10 years | 0.38 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ALVOX | 131.34 | 1.58 | +1.22% |
Alger Capital Appreciation Ptfl I-2 | |||
PRDSX | 44.15 | 0.47 | +1.08% |
T. Rowe Price Integrated US Sm Gr Eq | |||
CMCIX | 26.96 | 0.20 | +0.75% |
Calvert Small/Mid-Cap I | |||
MENIX | 9.42 | 0.03 | +0.32% |
Madison Covered Call & Equity Income I | |||
MDBAX | 20.19 | 0.03 | +0.15% |
BlackRock Large Cap Focus Value Inv A |